First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations
Cheunkarndee, Tia, Guo, Matthew Z., Houseknecht, Stefanie, Feliciano, Josephine L., Hann, Christine L., Lam, Vincent K., Levy, Benjamin P., Murray, Joseph C., Brahmer, Julie R., Forde, Patrick M., Marrone, Kristen A., Scott, Susan C.
Published in JTO clinical and research reports (01.06.2024)
Published in JTO clinical and research reports (01.06.2024)
Get full text
Journal Article
Survival of Asian females with advanced lung cancer in the era of tyrosine kinase inhibitor therapy
Becker, Daniel J., MD, MS, Wisnivesky, Juan P., MD, PhD, Grossbard, Michael L., MD, Chachoua, Abraham, MD, Camidge, D. Ross, MD, PhD, Levy, Benjamin P., MD
Published in Clinical lung cancer (01.01.2017)
Published in Clinical lung cancer (01.01.2017)
Get full text
Journal Article